![](/img/cover-not-exists.png)
Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia
Shahina Daar, Anil Pathare, Hanspeter Nick, Ulrike Kriemler-Krahn, Abdel Hmissi, Dany Habr, Ali TaherVolume:
82
Year:
2009
Language:
english
Pages:
4
DOI:
10.1111/j.1600-0609.2008.01204.x
File:
PDF, 141 KB
english, 2009